(Q38429857)

3 September 2017

title

Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression (English)

1 reference

3 September 2017

0 references

1

Janine G Einspahr

1 reference

3 September 2017

11

David S Alberts

1 reference

3 September 2017

Tracy L Thomas

2

1 reference

3 September 2017

Kathylynn Saboda

3

1 reference

3 September 2017

Brian J Nickolof

4

1 reference

3 September 2017

James Warneke

5

1 reference

3 September 2017

Clara Curiel-Lewandrowski

6

1 reference

3 September 2017

James Ranger-Moore

7

1 reference

3 September 2017

Laura Duckett

8

1 reference

3 September 2017

Jerry Bangert

9

1 reference

3 September 2017

John P Fruehauf

10

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

3 September 2017

1 reference

3 September 2017

volume

110

1 reference

3 September 2017

issue

11

1 reference

3 September 2017

page(s)

2519-2527

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

3 September 2017

1 reference

Telomerase activity in melanocytic lesions: A potential marker of tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Underreporting of cutaneous melanoma in cancer registries nationwide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Skin cancer prevention for children: a critical review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Malignant melanoma: prevention, early detection, and treatment in the 21st century

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Chemoprevention of melanoma: theoretical and practical considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Melanoma chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

The precursors of malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Melanoma etiology: where are we?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Cutaneous melanomas associated with nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Clinical practice. Dysplastic nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Natural history of dysplastic nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Dysplastic nevi. Markers for increased risk for melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Grading of atypia in nevi: correlation with melanoma risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Loss of heterozygosity detected on 1p and 9q in microdissected atypical nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Angiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

The biology of vascular endothelial growth factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Immunohistochemical markers of melanocytic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23076

7 January 2021

Identifiers

DOI

10.1002/CNCR.23076

1 reference

3 September 2017

1 reference